Discontinued — last reported Q2 '21
JPMorgan Chase Net Cash Collateral Received - Derivative Instruments increased by 2.2% to $51.10B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 14.3%, from $44.70B to $51.10B. Over 4 years (FY 2020 to FY 2024), Net Cash Collateral Received - Derivative Instruments shows a downward trend with a -12.4% CAGR.
net_cash_collateral_received_derivatives| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $70.00B | $68.80B | $67.60B | $68.50B | $64.60B | $77.40B | $51.50B | $47.80B | $52.50B | $57.80B | $48.30B | $47.60B | $48.30B | $44.70B | $51.90B | $46.90B | $50.00B | $51.10B |
| QoQ Change | — | -1.7% | -1.7% | +1.3% | -5.7% | +19.8% | -33.5% | -7.2% | +9.8% | +10.1% | -16.4% | -1.4% | +1.5% | -7.5% | +16.1% | -9.6% | +6.6% | +2.2% |
| YoY Change | — | — | — | — | -7.7% | +12.5% | -23.8% | -30.2% | -18.7% | -25.3% | -6.2% | -0.4% | -8.0% | -22.7% | +7.5% | -1.5% | +3.5% | +14.3% |
We use cookies for analytics. See our Privacy and Cookie Policy.